Multicenter phase III clinical trial of otilonium bromide in irritable bowel syndrome.
Kaushik
A
A
Pursnani
M L
ML
Kar
P
P
D000328:Adult; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D006801:Humans; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*
D002121:Calcium Channel Blockers; D000644:Quaternary Ammonium Compounds; C013934:octylonium